When the U.S. Food and Drug Administration places a shipment under Detention Without Physical Examination (DWPE), the agency is allowing field inspectors to automatically detain products entering the United States based on past compliance concerns. Instead of inspecting each shipment individually, the FDA may hold shipments because previous violations indicate that the product or manufacturer may not meet U.S. regulatory requirements.

DWPE is most commonly associated with FDA Import Alerts, which instruct inspectors to stop shipments from certain manufacturers, exporters, or product categories. When a company is subject to DWPE, shipments are typically detained at the port of entry until the importer can provide evidence demonstrating that the product complies with FDA regulations.

For companies exporting products into the United States, DWPE can disrupt supply chains, delay distribution, and create significant financial losses. Importers must respond quickly and provide proper regulatory documentation to demonstrate compliance.

FDA Registration Assistance provides professional regulatory support for companies dealing with FDA detentions, helping importers understand the cause of DWPE and develop a strategy to resolve compliance issues so shipments can move through U.S. ports more smoothly.

Trusted by more than 1,000 companies across 135+ countries, FDA Registration Assistance supports businesses facing FDA regulatory challenges and helps restore access to the U.S. market.

Why the FDA Uses Detention Without Physical Examination

The FDA uses DWPE when there is evidence suggesting that products from a specific manufacturer, exporter, or product category may violate U.S. regulatory standards. This enforcement approach allows the FDA to prevent potentially unsafe or noncompliant products from entering the marketplace without inspecting every shipment individually.

DWPE often occurs when repeated violations are discovered during inspections or import reviews. These violations may include labeling issues, contamination concerns, registration problems, or manufacturing practices that do not meet regulatory standards.

When a company or product is placed under DWPE, importers must demonstrate that the shipment meets FDA requirements before it can be released.

FDA Registration Assistance helps companies evaluate the regulatory concerns associated with their detention and prepare the documentation required to address them.

Common Reasons Products Are Placed Under DWPE

Several regulatory issues can lead to detention without physical examination. Products may be detained if the FDA identifies repeated violations related to labeling compliance, contamination risks, improper manufacturing practices, or missing registration records.

Food products may be detained due to lack of proper FDA Food Facility Registration, failure to maintain Foreign Supplier Verification Program documentation, or misbranded labeling. Pharmaceutical products may face detention due to issues related to Drug Establishment Registration or drug listing records. Cosmetic products may be detained if the manufacturing facility is not properly registered or if labeling claims violate regulatory standards.

When shipments are detained, companies must determine the exact reason for the detention before attempting to resolve the issue.

FDA Registration Assistance works with companies to identify compliance gaps and develop corrective strategies that address FDA concerns.

How FDA Registration Assistance Helps Resolve FDA Detentions

Responding to a DWPE situation requires a structured approach. Importers must review the regulatory concerns associated with the detention and provide documentation that demonstrates compliance with FDA regulations.

FDA Registration Assistance helps companies evaluate the cause of detention, review regulatory records, and organize the documentation required to support product release. Our team works with manufacturers, importers, and regulatory personnel to ensure that compliance issues are properly addressed.

In many cases, resolving detention issues involves reviewing facility registrations, confirming importer compliance programs, evaluating labeling documentation, and preparing regulatory explanations that clarify the product’s compliance status.

By working with FDA Registration Assistance, companies receive professional guidance on navigating complex FDA regulatory procedures.

Preventing Future FDA Detentions

Companies that experience FDA detention should also focus on preventing future compliance issues. Regulatory systems should be reviewed to ensure that facility registrations, product documentation, and labeling requirements remain accurate.

FDA Registration Assistance helps companies strengthen their regulatory compliance programs, ensuring that their supply chains meet FDA requirements before products are shipped to the United States.

This proactive approach helps reduce the risk of future detentions and supports long-term access to the U.S. market.

Work With FDA Registration Assistance

If your company is facing FDA Detention Without Physical Examination, responding quickly and accurately is essential to minimize supply chain disruptions.

FDA Registration Assistance provides professional regulatory support to help companies evaluate FDA detentions, identify compliance issues, and work toward restoring normal import operations.

With experience assisting companies in more than 135 countries, FDA Registration Assistance helps businesses navigate complex FDA regulations and maintain compliance with U.S. import requirements.

Contact FDA Registration Assistance today to begin addressing your FDA detention situation.

Frequently Asked Questions About FDA Detention Without Physical Examination

1. What is FDA Detention Without Physical Examination?

Detention Without Physical Examination, often abbreviated as DWPE, is an FDA enforcement action that allows inspectors to automatically detain shipments entering the United States based on previous regulatory concerns. Instead of inspecting each shipment individually, the FDA may detain products if past violations suggest that similar shipments may not comply with regulatory standards.

This process helps the FDA prevent potentially unsafe or noncompliant products from entering the U.S. market.

2. What does it mean if my shipment is under DWPE?

If your shipment is subject to detention without physical examination, it means the FDA has determined that the product, manufacturer, or exporter may present regulatory concerns. The shipment will typically be held at the port of entry until the importer provides evidence demonstrating compliance.

Importers must work with regulators and review documentation to determine the cause of the detention.

3. What causes the FDA to place products under DWPE?

Products may be placed under DWPE when the FDA identifies repeated regulatory violations associated with a specific manufacturer or product category. These violations may involve contamination risks, labeling deficiencies, improper manufacturing practices, or missing regulatory documentation.

The FDA uses DWPE to prevent potential violations from entering the market.

4. Is DWPE the same as an Import Alert?

DWPE is often associated with FDA Import Alerts. An Import Alert allows the FDA to instruct inspectors to detain shipments from certain manufacturers or products without conducting physical inspections.

DWPE is the enforcement mechanism used to carry out Import Alerts.

5. Can a company be removed from DWPE?

Yes. Companies can work toward removal from DWPE by demonstrating that the regulatory issues that caused the detention have been corrected. This typically involves providing evidence of compliance and addressing the root cause of the violation.

6. What happens to shipments that are detained?

Shipments placed under DWPE are usually held at the port until the importer provides documentation demonstrating compliance. If the importer cannot provide sufficient evidence, the shipment may be refused entry.

7. Do food products frequently face DWPE?

Yes. Food products are among the most commonly detained imports due to issues related to labeling, contamination risks, or regulatory documentation.

8. Can cosmetic products be detained by the FDA?

Yes. Cosmetic products may be detained if they violate FDA labeling rules, contain prohibited ingredients, or fail to comply with regulatory requirements.

9. Can pharmaceutical products be subject to DWPE?

Yes. Drug products may be detained if the manufacturing facility is not properly registered or if the product violates regulatory standards.

10. What should companies do if a shipment is detained?

Companies should immediately review the detention notice and determine the regulatory issue involved. Working with regulatory professionals can help identify compliance gaps and determine the appropriate corrective actions.

11. Can labeling issues lead to detention?

Yes. Misbranded or incorrectly labeled products may be detained because labeling compliance is an important regulatory requirement.

12. Does FDA inspect every shipment entering the U.S.?

No. The FDA uses risk-based monitoring systems to identify shipments that may require inspection or detention.

13. Can repeated violations lead to import restrictions?

Yes. Repeated regulatory violations may result in import alerts or continued detention of shipments.

14. How can companies avoid DWPE?

Maintaining proper regulatory compliance, including accurate labeling, facility registration, and documentation, can help reduce the risk of detention.

15. How can FDA Registration Assistance help with DWPE?

FDA Registration Assistance helps companies evaluate FDA detention situations, identify compliance gaps, and develop strategies to address regulatory concerns and restore access to the U.S. market.